Virtual Medicinal Product (VMP)
-
Bumetanide 5mg tablets
Name Details
Current Name
Bumetanide 5mg tablets
|
Start Date
SOT
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
C03CA02
BNF |
Current BNF
02020200
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
02020200
|
Start Date
01-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
42292711000001105 |
29-09-2023 |
|
318022002 |
SOT |
28-09-2023 |
VMP Ingredients
VMP ingredients table
Bumetanide |
Based on Ingredient Substance |
|
5 mg |
|
Name
Bumetanide
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
5
Strength and UOM (Dmr)
Parent Products
-
VTM
Bumetanide
-
VMP
(Current) Bumetanide 5mg tablets
Virtual Medicinal Product Pack (VMPP) Information